(
out of
366
reviews
)
Board Certification
|
American Board of Internal Medicine (Sub: Gastroenterology)
American Board of Internal Medicine (Sub: Transplant Hepatology)
Mexican Board of Gastroenterology
Mexican Board of Gastroenterology (Sub: Gastrointestinal Endoscopy)
Mexican Board of Internal Medicine
|
Patient Rating
Patients consistently describe Dr. Gallegos as knowledgeable, compassionate, and highly skilled in liver care. Many praise his clear, easy-to-understand explanations, attentive listening, and willingness to take time with questions, including communicating in patients' preferred language. Reviewers also note his personable bedside manner and thoughtful, thorough approach that leaves them feeling confident in their treatment plans.
Generated via Patient Reviews
4.9
/5
( out of
366 reviews
)
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Internal Medicine
-Professor (Clinical) |
|---|---|
| Academic Divisions |
Gastroenterology
|
| Board Certification |
American Board of Internal Medicine (Sub: Gastroenterology)
American Board of Internal Medicine (Sub: Transplant Hepatology)
Mexican Board of Gastroenterology
Mexican Board of Gastroenterology (Sub: Gastrointestinal Endoscopy)
Mexican Board of Internal Medicine
|
Education history
| Fellowship | Transplant Hepatology - Mayo Clinic College of Medicine, Mayo Clinic in Arizona | Fellow |
|---|---|---|
| Fellowship | Gastroenterology - Mayo Clinic College of Medicine, Mayo Clinic in Arizona | Fellow |
| Residency | Internal Medicine - Mayo Clinic College of Medicine | Resident |
| Fellowship | Gastroenterology - Universidad Nacional Autónoma de México | Fellow |
| Residency | Internal Medicine - Universidad Nacional Autónoma de México | Resident |
| Clerkship | Cardiology - University of New Mexico Hospital, University of New Mexico Medical School | Clinical Clerkship |
| Clerkship | Gastroenterology - University of New Mexico Hospital, University of New Mexico Medical School | Clinical Clerkship |
| Professional Medical | Medicine with Honors, (Suma cum Laude equivalent) - Universidad Nacional Autónoma de México | M.D. |
Selected Publications
Journal Article
- Havens JR, Fluker SA, Schimmel J, McCrary LM, Miller LS, Udo T, Manabe YC, Luetkemeyer A, Burkholder G, Moon AM, Chastain CA, Price JC, Cafardi J, Gallegos-Orozco JF, Young BA, Young J, Aparicio C, Song Y, Lai E, Louw GE (2026). Performance Evaluation of the Xpert® HCV test on Fingerstick Blood in a Prospective Observational Clinical Study at CLIA-Waived Sites in the United States. Clin Infect Dis.
- Warner ZC, Turner CA, Alvarez R, Gallegos-Orozco JF, Green A, Warner EL (2026). Misinformation and Profitability of Hepatitis B Virus Claims on Instagram: Formative Cross-Sectional Study. JMIR Form Res, 10, e71584.
- Trauner M, Levy C, Tanaka A, Goodman Z, Thorburn D, Joshi D, Salminen K, Yimam K, Isayama H, Montano-Loza AJ, Caldwell S, Danta M, Farkkila M, Gallegos-Orozco JF, Gordon SC, Hinrichsen H, Invernizzi P, Vuppalanchi R, Zhu K, Xu J, Liu X, Lu X, Crans G, Bolbolan S, Boyette L, Alani M, Barchuk WT, Watkins TR, Genovese MC, Bowlus CL (2025). Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol, 11(1), 46-58.
- Trauner M, Levy C, Tanaka A, Goodman Z, Thorburn D, Joshi D, Salminen K, Yimam K, Isayama H, Montano-Loza AJ, Caldwell S, Danta M, Farkkila M, Gallegos-Orozco JF, Gordon SC, Hinrichsen H, Invernizzi P, Vuppalanchi R, Zhu K, Xu J, Liu X, Lu X, Crans G, Bolbolan S, Boyette L, Alani M, Barchuk WT, Watkins TR, Genovese MC, Bowlus CL (2025). Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol, 11(1), 46-58.
- Boike JR, Gallegos-Orozco JF, Duarte-Rojo A (2025). Rallentando un Poco : Carvedilol and Its Role in Cirrhosis Progression. Am J Gastroenterol.
- Gallegos-Orozco JF, OLeary JG, Reddy KG, Bindra J, Chopra I, Niewoehner J, Huang X (2025). Early Diagnosis and Timely Terlipressin in Hepatorenal Syndrome Improves Projected Outcomes and Lowers Cost. Clinicoecon Outcomes Res, 17, 615-625.
- Jensen MK, Gallegos-Orozco JF (2025). Less salt and more water for children-not just dietary, but transplant management too. Liver Transpl, 31(5), 569-570.
- Mohan BP, Iriana S, Khan SR, Yarra P, Ponnada S, Gallegos-Orozco JF (2022). Outcomes of liver transplantation in patients 70 years or older: a systematic review and meta-analysis. Ann Hepatol, 27(6), 100741.
- Mohan BP, Iriana S, Khan SR, Yarra P, Ponnada S, Gallegos-Orozco JF (2022). Outcomes of liver transplantation in patients 70 years or older: a systematic review and meta-analysis. Annals of Hepatology.
- Izzy M, Fortune BE, Serper M, Bhave N, deLemos A, Gallegos-Orozco JF, Guerrero-Miranda C, Hall S, Harinstein ME, Karas MG, Kriss M, Lim N, Palardy M, Sawinski D, Schonfeld E, Seetharam A, Sharma P, Tallaj J, Dadhania DM, VanWagoner LB (2022). Management of Cardiac Diseases in Liver Transplant Recipients: Comprehensive Review and Multidisciplinary Practice-Based Recommendations. PMID: 35359027. American Journal of Transplant.
- Wong YJ, Qiu TY, Tam YC, Mohan BP, Gallegos-Orozco JF, Adler DG (2020). Efficacy and Safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: A systematic review and meta-analysis. Dig Liver Dis, 52(10), 1137-1142.
- Bajaj JS, Brenner DM, Cai Q, Cash BD, Crowell M, DiBaise J, Gallegos-Orozco JF, Gardner TB, Gyawali CP, Ha C, Holtmann G, Jamil LH, Kaplan GG, Karsan HA, Kinoshita Y, Lebwohl B, Leontiadis GI, Lichtenstein GR, Longstreth GF, Muthusamy VR, Oxentenko AS, Pimentel M, Pisegna JR, Rubenstein JH, Russo MW, Saini SD, Samadder NJ, Shaukat A, Simren M, Stevens T, Valdovinos M, Vargas H, Spiegel B, Lacy BE (2020). Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology. Am J Gastroenterol, 115(7), 1007-1018.
- Rofaiel G, Martinez E, Pan G, Sossenheimer M, OHara R, Gallegos J, Box T, Pham T, Campsen J, Goodale M, Kim R (2019). Creation of a Robotically Assisted Terminal Jejunogastrostomy Is Safe and Effective in Regaining Antegrade Enteral Bile Duct Access After Live Donor Liver Transplant With Roux Limb. Transplant Direct, 5(8), e476.
- Garcia-Tsao G, Fuchs M, Shiffman M, Borg BB, Pyrsopoulos N, Shetty K, Gallegos-Orozco JF, Reddy KR, Feyssa E, Chan JL, Yamashita M, Robinson JM, Spada AP, Hagerty DT, Bosch J (2018). Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension. Hepatology, 69(2), 717-728.
- Charlton M, Levitsky J, Aqel B, OGrady J, Hemibach J, Rinella M, Fung J, Ghabril M, Thomason R, Burra P, Little EC, Berenguer M, Shaked A, Trotter J, Roberts J, Rodriguez-Davalos M, Rela M, Pomfret E, Heyrend C, Gallegos-Orozco J, Saliba F (2018). International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. Transplantation, 102(5), 727-743.
- Gallegos-Orozco JF, Charlton MR (2017). Predictors of Cardiovascular Events After Liver Transplantation. Clin Liver Dis, 21(2), 367-379.
- Samadder NJ, Smith KR, Wong J, Hanson H, Boucher K, Burt RW, Charlton M, Byrne KR, Gallegos-Orozco JF, Koptiuch C, Curtin K (2016). Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah. Dig Dis Sci, 61(12), 3627-3632.
- Gallegos-Orozco JF, Kim R, Thiesset HF, Hatch J, Lynch K, Chaly T Jr, Shihab F, Ahmed F, Hall I, Campsen J (2016). Early Results of Pilot Study Using Hepatitis C Virus (HCV) Positive Kidneys to Transplant HCV Infected Patients with End-Stage Renal Disease Allowing for Successful Interferon-Free Direct Acting Antiviral Therapy after Transplantation. Cureus, 8(11), e890.
- Gallegos-Orozco JF, Silva AC, Batheja MJ, Chang YH, Hansen KL, Lam-Himlin D, De Petris G, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan DC, Silva AM, Rakela J, Vargas HE (2015). Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Abdom Imaging, 40(4), 795-802.
- Porres-Aguilar M, Gallegos-Orozco JF (2014). Hepatopulmonary syndrome: Is it time to redefine the MELD exception score for better organ allocation and outcomes? Ann Hepatol, 13(4), 468-70.
- Murad MH, Fernndez-Balsells MM, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA, Lampropulos JF, Natividad I, Perestelo-Prez L, Ponce de Len-Lovatn PG, Albuquerque FN, Carey J, Erwin PJ, Montori VM (2010). Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Clin Endocrinol (Oxf), 73(6), 777-91.
- Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE (2009). Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course. Liver Transpl, 15(12), 1872-81.
Review
- Izzy M, Fortune BE, Serper M, Bhave N, deLemos A, Gallegos-Orozco JF, Guerrero-Miranda C, Hall S, Harinstein ME, Karas MG, Kriss M, Lim N, Palardy M, Sawinski D, Schonfeld E, Seetharam A, Sharma P, Tallaj J, Dadhania DM, VanWagner LB (2022). Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations. [Review]. Am J Transplant, 22(12), 2740-2758.
- Izzy M, Fortune BE, Serper M, Bhave N, deLemos A, Gallegos-Orozco JF, Guerrero-Miranda C, Hall S, Harinstein ME, Karas MG, Kriss M, Lim N, Palardy M, Sawinski D, Schonfeld E, Seetharam A, Sharma P, Tallaj J, Dadhania DM, VanWagner LB (2022). Management of Cardiac Diseases in Liver Transplant Recipients: Comprehensive Review and Multidisciplinary Practice-Based Recommendations. [Review]. Am J Transplant, 22(12), 2740-2758.
- Chandna S, Zarate ER, Gallegos-Orozco JF (2021). Management of Decompensated Cirrhosis and Associated Syndromes. [Review]. Surg Clin North Am, 102(1), 117-137.
- Chandna S, Rodriguez Zarate E, Gallegos-Orozco JF (2021). Management of decompensated cirrhosis and associated syndromes. [Review]. Surg Clin North Am, 102, 117-137.
- Gallegos-Orozco JF, Charlton M (2017). Predictors of cardiovascular events after liver transplantation. [Review]. Clin Liver Dis, 21(2), 367-379.
- Gallegos-Orozco JF, Charlton MR (2016). Alcoholic Liver Disease and Liver Transplantation. [Review]. Clin Liver Dis, 20(3), 521-34.
- Unzueta A, Gallegos-Orozco JF (2013). Noninvasive diagnosis of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Oncology Gastroenterology Hepatology Reports. [Review]. Oncology, 2, 8-16.
- Porres-Aguilar M, Gallegos-Orozco JF, Garcia H, Aguirre J, Macias-Rodriguez RU, Torre-Delgadillo A (2013). Pulmonary vascular complications in portal hypertension and liver disease: a concise review. [Review]. Rev Gastroenterol Mex, 78(1), 35-44.
- Gallegos-Orozco JF, Foxx-Orenstein AE, Sterler SM, Stoa JM (2012). Chronic constipation in the elderly. [Review]. Am J Gastroenterol, 107(1), 18-25; quiz 26.
Book Chapter
- Gallegos-Orozco JF (2023). Hepatitis por inhibidores del punto de control inmunitario [Immune checkpoint inhibitor hepatitis]. In Yamamoto Furusho JK, Uscanga Dominguez LF (Eds.), Enfermedades del aparato digestivo inmunomediadas [Immune mediated diseases of the digestive system] (pp. 83-88). Mexico City, Mexico: Permanyer.
- Aguilar MT, Chandna S, Gallegos-Orozco JF (2023). Primary Sclerosing Cholangitis. In Yamamoto Furusho JK, Uscanga Dominguez LF (Eds.), Enfermedades del aparato digestivo inmunomediadas [Immune mediated diseases of the digestive system] (pp. 95-102). Mexico City, Mexico: Permanyer.
- Unzueta A, Gallegos-Orozco JF (2017). Factores de riesgo en tumores hepaticos [Risk factors for liver tumors]. In Chirino-Sprung RA, Torre-Delgadillo A (Eds.), XII Congreso Nacional de Hepatologia (First, pp. 121-125). Mexico City: Permanyer.
- Unzueta Santos A, Gallegos-Orozco JF (2016). Fibrosis hepática: nuevas alternativas terapéuticas. [Liver fibrosis: new therapeutic options]. In Uscanga L (Ed.), 70 años de Gastroenterología en el Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán: Los Grandes Temas del Departamento (pp. 13-18). Mexico City, Mexico: Permanyer Mexico.
- Garca Senz de Sicilia M, Gallegos-Orozco JF (2016). Tratamiento actual de la hepatitis crónica por virus de la hepatitis C [Current treatment of chronic hepatitis C]. In Uscanga L. (Ed.), 70 años de Gastroenterología en el Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán: Los Grandes Temas del Departamento (pp. 119-124). Mexico City, Mexico: Permanyer Mexico.
- Doycheva I, Gallegos-Orozco JF (2016). Acute viral hepatitis: hepatitis A, hepatitis E and other viruses. In Talley NJ, DeVault KR, Wallace MB, Aqel B, Lindor KD (Eds.), Practical Gastroenterology and Hepatology Board Review Toolkit (2nd Edition, pp. 465-72). Oxford: Wiley-Blackwell.
- Gallegos-Orozco JF (2015). Tratamiento actual del enfermo con hepatitis crónica por hepatitis C: un ejemplo de medicina traslacional [Current treatment of chronic hepatitis C: an example of translational medicine]. In Torre A, Uscanga-Domínguez LF (Eds.), Medicina individualizada: de la evidencia a la práctica clínica (pp. 43-49). Mexico City, Mexico: Permanyer Mexico.
- Gallegos-Orozco JF, Campsen J (01/01/2015). Liver transplant-related malignancies. In Busuttil W, Klintmalm GB (Eds.), Transplantation of the Liver (3rd Edition, pp. 1191-1209). Saunders.
- Pham T, Gallegos-Orozco JF (01/01/2014). New treatments for chronic hepatitis C. In Uscanga-Domínguez LF, Yamamoto-Furusho JK (Eds.), Gastroenterología Translacional. La investigación básica al servicio de la práctica clínica. Barcelona: Permanyer Publications.
- Hatch J, Gallegos-Orozco JF (2013). Preoperative evaluation of patients with cirrhosis. In Gonzalez-Huezo MS, Sanchez-Avila JF (Eds.), Hepatología: de la ciencia básica a la aplicación clínica (pp. 107-12). Mexico City: ZarPra Ediciones.
- Porres-Aguilar M, Gallegos-Orozco JF (2013). Pulmonary complications in liver cirrhosis. In Gonzalez-Huezo MS, Sanchez-Avila JF (Eds.), Hepatología: de la ciencia básica a la aplicación clínica (pp. 153-7). Mexico City: ZarPra Ediciones.
- Unzueta A, Gallegos-Orozco JF (2012). Esteatohepatitis no alcohólica, ¿Cuál es el mejor método diagnóstico? In Torre-Delgadillo A, Kershenobich D (Eds.), Tópicos Innovadores en Hepatología (1st Edition, pp. 265-74). Mexico City: ZarPra Ediciones.
- Costilla VC, Gallegos-Orozco JF (2012). Terapias biológicas en el hepatocarcinoma. In Torre-Delgadillo A, Kershenobich D (Eds.), Tópicos Innovadores en Hepatología (1st Edition, pp. 373-88). Mexico City: ZarPra Ediciones.
- Gallegos-Orozco JF, Vargas HE (2012). Drug-Induced, Granulomatous, and Other Inflammatory Hepatic Diseases. In DiBaise J (Ed.), Gastroenterology and Hepatology Board Review: Pearls of Wisdom (3rd Edition, pp. 389-98). New York: McGraw-Hill Medical.
Case Report
- Chaly T, Campsen J, OHara R, Hardman R, Gallegos-Orozco JF, Thiesset H, Kim RD (2017). Mucocele mimicking a gallbladder in a transplanted liver: A case report and review of the literature. World J Transplant, 7(6), 359-363.
- Horner BJ, Craig R, Harris ES, Kovacsovics T, Gallegos-Orozco JF (2017). Acute liver failure secondary to AL amyloidosis. Clin Med Rev Case Rep, 4(2), 157.
- Gallegos-Orozco JF, Gurudu SR, Orenstein R (2012). First successful colonoscopic fecal transplant for severe acute Clostridium difficile pseudomembranous colitis. Rev Gastroenterol Mex.
- Werner KT, Gallegos-Orozco JF (2012). Multiple hepatic abscesses secondary to chicken bone penetration of the colon: a case report. Rev Gastroenterol Mex, 77(1), 43-6.
- Gallegos-Orozco JF, Paskvan-Gawryletz CD, Gurudu SR, Orenstein R (2012). Successful colonoscopic fecal transplant for severe acute Clostridium difficile pseudomembranous colitis. Rev Gastroenterol Mex, 77(1), 40-2.
Editorial
- Gallegos-Orozco JF (2019). The Growing Challenge of Advanced Liver Disease Due to Alcohol Use in the United States. Am J Gastroenterol, 114(11), 1712-1713.
- Gallegos-Orozco JF, Charlton MR (2015). Treatment of HCV prior to liver transplantation to prevent HCV recurrence - wise or wasteful? Liver Int, 35(1), 9-11.
Abstract
- Campsen J, Kim R, Thiesset H, Chaly T, Shihab F, Ahmed F, Gallegos-Orozco JF (2016). Expanding the donor pool using HCV+ kidneys to cure HCV and end-stage renal disease. [Abstract]. American Journal of Transplantation, 16(S1), 44-45.
- Abduljawad B, Hatch J, Lynch KM, Stevens K, Thomason IR, Box TD, Gallegos-Orozco JF (2016). Real world experience with interferon-free direct acting antivirals in the treatment of patients with chronic hepatitis C. Accepted for presentation during DDW in San Diego, California, USA, May 2016. [Abstract]. Gastroenterology, 150(Supplement 1), S1104.
- Parbhu SK, Haseeb A, Gallegos-Orozco JF (01/15/2015). Ursodeoxycholic acid (UDCA) therapy in acute cytomegalovirus (CMV) hepatitis associated cholestasis. Accepted for presentation at the 80th Annual Meeting of the American College of Gastroenteorlogy in Honolulu, Hawaii. [Abstract].
- Haseeb A, Gallegos-Orozco JF (11/07/14). Hepatic encephalopathy, a preventable readmission: implementation of quality indicators at a tertiary care center. 65th Annual Meeting of the American Association for the Study of Liver Diseases in Boston, MA. [Abstract]. Hepatology, (Supp 60), 397A.
- Unzueta A, Moreira RK, De Petris G, Smith ML, Chang Y-H H, Cheng M-R, Eyshou A, Gallegos-Orozco JF, Aqel B, Vargas HE (11/07/14). Validation of the hepatitis aggressiveness score in a liver transplant population with recurrent hepatitis C. 65th Annual Meeting of the American Association for the Study of Liver Diseases in Boston, MA. [Abstract]. hepatology, (Supp 60), 535A.
- Chervenak AE, Bashar A, Byrne TJ, Carey EJ, Rakela J, Hartel LA, Gallegos-Orozco JF, Sapola AM, Vargas HE (2012). Treatment of HCV in the DAA era: the impact of a multidisciplinary team. Presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases in Boston, MA. [Abstract]. Hepatology, 56(Suppl), 228A.
- Gallegos-Orozco JF, Chervenak AE, Carey EJ, Bashar A, Byrne TJ, Hartel LA, Rakela J, Vargas HE (2012). Liver transplant center focused experience with peginterferon alfa-2ª, ribavirin and telaprevir therapy in patients with genotype 1 hepatitis C cirrhosis. Presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases in Boston, MA, [Abstract]. Hepatology, 56(Suppl), 218A-219A.
- Gallegos-Orozco JF, Silva AM, Chang Y-H, Batheja MJ, Hansen KL, Lam-Himlin D, De Petris G, Carey EJ, Aqel BA, Byrne TJ, Douglas DD, Mulligan DC, Silva A, Vargas HE (2012). Magnetic resonance elastography (MRE) can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Young Investigator Award Winner. Presented at the International Liver Transplantation Society 17th Annual International Congress. San Francisco, CA. [Abstract]. Liver Transpl, 18(Suppl 1), S111.
- Gallegos-Orozco JF, Silva AM, Chang Y-H, Batheja MJ, Hansen KL, Lam-Himlin D, De Petris G, Carey EJ, Aqel BA, Byrne TJ, Douglas DD, Mulligan DC, Rakela J, Silva A, Vargas HE (2012). Magnetic resonance elastography (MRE) can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Presented at the International Liver Congress in Barcelona, Spain. [Abstract]. J Hepatol, (56), S96.
Dr. Gallegos has been my liver doctor for years, and I couldn't ask for better care. He has always been kind, compassionate, and truly takes the time to listen. He never makes me feel rushed and always explains everything in a way I can understand. Through every step of my health journey, he's been there for me. I'm so grateful for his care and would highly recommend him to anyone looking for a doctor who truly cares about his patients.
Great communicator
Thank you Dr Gallegos
Very happy with the service I received. Thank you.
Very friendly and knowledgeable
He explained everything very well'he gave us time to talk and ask him our questions. Thank you, doctor, for all your help and support. [TRANSLATED]
Dr. Gallegos is a caring physician who caters his care to the individual. He is well respected and is a valuable faculty member at University Health Care.
My first visit with Juan F Gallegos-Orozco gives me added hope and belief that even though I have a severe health condition, I am in good hands and will receive outstanding direction and loving care.
Super nice DR. and very caring. I also think he is very fun /funny. Will answer all questions he can and explains things very well.
Gallegos is the man
Very friendly and professional, answered all my questions in a easy to understand way. Good sense of humor also I might say.
A very caring doctor, I really liked him
Meeting with Dr. Gallegos was very personable. His explanations to my needs, questions and assessment on my condition were easily understood. Dr. Gallegos was focused on my condition and was in no rush. It was a great pleasure to meet Dr. Gallegos and look forward to our future visits.
Dr. Gallegos is as good as a liver doctor can be, in my opinion. He cares and listens. I have seen him in person and on video appointments. He and others have kept me in check for going on 11 years., with my post liver transplant. If thanks is really good enough, THANKS. And they continue to be here for me, thanks for all the care you give!
Dr. Gallegos cares a great deal about his patients. He is a Hepatology Subject Matter Expert who takes the time to explain things to help patients understand their condition, with a proactive healthcare plan forward. I trust this physician.
Very professional but very caring
If you find yourself with unexpected liver disease, you will be safe and your disease will be addressed with care, concern and expertise.
A very attentive and generous doctor in what he teaches you. I always noticed his interest in my answers. [TRANSLATED]
Dr. Juan Gallegos-Orozco approached my visit with him with such kindness and dignity. He shared his wealth of knowledge and advice. I fully understood all that he said and recommended to me. I was so fortunate to have met this fine physician and I feel more healthy for having done so.
Very attentive and explains in a very easy to understand way. [TRANSLATED]
Dr. Juan F Gallegos-Orozcois attentive, compassionate, professional and knowledgeable. He has always had my best interest at heart. He listens and is quite accommodating! I just think he's the best!
Very professional and great bedside manner. Answers all questions. Gives you time to talk.
Knowledgeable, professional, respectful and experienced.
Very thorough. Took the time to explain what was going on and made sure you understood. Explained treatment plan in detail.
Dr. Gallegos is the best liver transplant doctor to have on your team! He is thoughtful, extremely intelligent, and treats me with kindness. I am lucky to have this care!
He is the Best!!!
Doctor Gallegos covered all the corners of my medical care. He communicates his ideas clearly, and in my native language which is convenient for me.
Dr. Gallegos-Orozco is committed to my success in healing the conditions that ail me. He does so with acceptance and authentic care. I am honored to receive his help. guidance, and assistance toward full health, as best that can be achieved.
He is a very specific and very professional doctor, always aware of my health. [TRANSLATED]
I have much respect for Dr. Gallegos as he has provided valuable insight.
Dr. Gallegos is very attentive, speaks my language, explains my treatment very well, and cares about my health. [TRANSLATED]
Dr. Gallegos was very attentive to my questions/concerns, and was thorough in probing me about my current condition..
Thank you for being such a brilliant, thorough, and caring doctor. I appreciate your commitment to my total health regardless of the variance of symptoms.
Dr Gallegos-Orozco has been great. I started with appointments with him. He is a great Dr
Dr Gallegos is really nice and informative and explains things really well, I enjoy my visits with him.
Thank you Dr.Gallegos for being such a great dr I appreciate everything you do.
Great Doctor
Dr. Gallegos is a highly educated, compassionate, professional Physician. He allows me to be a part of my care but at same time giving his expert opinion. I always follow his advice but he listens, making me a part of overall care. ItÕs important to caregiving- he is wonderful. Priscilla his nurse along with PA Jaime are exceptional. Great Team!
He's such a pleasant gentleman it's almost worth getting sick to be treated by him
He put things in line for me to understand about my liver and about exercising to lose the weight so I can have the liver transplant plus to take care of myself and be healthy so this can happen.
He is amazing!
The doctor was very nice and informative. He gave me great advice. I thank him for his advice and time.
he is a fantastic doctor. He is kind great listener explains things extensively if needed.